Table 2 Clinical features of epilepsy among participants
Variables | Group 1 N = 35 N (%) | Group 2 N = 18 N (%) | Group 3 N = 31 N (%) | Group 4 N = 15 N (%) | Group 5 N = 40 N (%) | P value |
|---|---|---|---|---|---|---|
Frequency of seizures | ||||||
Less than 6 times\month | 35 (100%) | 15 (83.3%) | 28 (90.3%) | 9 (60%) | 32 (80%) | 0.000* |
More than 6 times\month | 0 (0%) | 3 (16.7%) | 3 (9.7%) | 6 (40%) | 8 (20%) | |
Type of seizures | ||||||
Generalized | 0 (0%) | 18 (100%) | 20 (70.9%) | 15 (100%) | 21 (52.5%) | 0.000* |
Partial | 35 (100%) | 0 (0%) | 5 (16.1%) | 0 (0%) | 19 (47.5%) | |
Absence | 0 (0%) | 0 (0%) | 2 (6.5%) | 0 (0%) | 0 (0%) | |
Myoclonus | 0 (0%) | 0 (0%) | 2 (6.5%) | 0 (0%) | 0 (0%) | |
Duration of illness | ||||||
Less than 5 years | 11 (31.4%) | 1 (5.6%) | 11 (35.5%) | 0 (0%) | 40 (100%) | 0.001* |
5–10 years | 18 (51.4%) | 5 (27.8%) | 10 (32.3%) | 12 (80%) | 0 (0%) | |
More than 10 years | 6 (17.1%) | 12 (66.7%) | 10 (32.3%) | 3 (20%) | 0 (0%) | |
EEG changes | ||||||
Non-specific changes | 27 (77.2%) | 8 (44.4%) | 19 (61.3%) | 12 (80%) | 14 (35%) | 0.0003* |
Generalized | 0 (0%) | 10 (55.6%) | 3 (9.7%) | 3 (20%) | 15 (37.5) | |
Focal | 8 (22.8%) | 0 (0%) | 9 (29%) | 0 (0%) | 11 (27.5%) | |
1. Temporal site | 6 (17.1%) | 0 (0%) | 7 (22.5%) | 0 (0%) | 7 (17.5%) | |
2. Frontal site | 2 (5.7%) | 0 (0%) | 2 (6.5%) | 0 (0%) | 4 (10%) | |